Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
242.54
-0.98 (-0.40%)
Dec 20, 2024, 4:00 PM EST - Market closed
Penumbra Market Cap
Penumbra has a market cap or net worth of $9.31 billion as of December 20, 2024. Its market cap has increased by 8.06% in one year.
Market Cap
9.31B
Enterprise Value
9.24B
1-Year Change
8.06%
Ranking
Category
Stock Price
$242.54
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $9.31B, an increase of 655.38%. That is a compound annual growth rate of 24.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 9.31B | -4.12% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exact Sciences | 10.38B |
| Doximity | 10.30B |
| Qiagen | 9.85B |
| Exelixis | 9.62B |
| Encompass Health | 9.45B |
| Charles River Laboratories International | 9.31B |
| Bio-Rad Laboratories | 9.13B |
| Bio-Rad Laboratories | 9.12B |